Antimicrobial and Antibiofilm Activity of Monolaurin against Methicillin-Resistant Staphylococcus aureus Isolated from Wound Infections

Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. The agar dilution method determined the minimum inhibitory concentration...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of microbiology Vol. 2024; no. 1; p. 7518368
Main Authors Hassan Abd El-Ghany, Shimaa Salah, Azmy, Ahmed Farag, Osama El-Gendy, Ahmed, Abd El-Baky, Rehab Mahmoud, Mustafa, Ahmad, Abourehab, Mohammed A S, El-Beeh, Mohamed E, Ibrahem, Reham Ali
Format Journal Article
LanguageEnglish
Published Egypt John Wiley & Sons, Inc 2024
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC ), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the gene. Monolaurin exhibited MIC values ranging from 500 to 2000  g/mL. FIC index showed a synergistic effect of monolaurin with -lactam antibiotics ranging from 0.0039 to 0.25 ( < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC values of 203.6  g/mL and 379.3  g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the gene were remarkably reduced at monolaurin concentrations of 250 and 500  g/mL. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.
AbstractList Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. Methods. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin’s antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene. Results. Monolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p<0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin’s capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL. Conclusion. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.
Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC ), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the gene. Monolaurin exhibited MIC values ranging from 500 to 2000  g/mL. FIC index showed a synergistic effect of monolaurin with -lactam antibiotics ranging from 0.0039 to 0.25 ( < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC values of 203.6  g/mL and 379.3  g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the gene were remarkably reduced at monolaurin concentrations of 250 and 500  g/mL. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.
Background . Methicillin‐resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life‐threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm‐forming MRSA. Methods . The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin’s antibiofilm activity and its inhibitory concentration (IC 50 ), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT‐PCR) discerned a monolaurin effect on the expression of the icaD gene. Results . Monolaurin exhibited MIC values ranging from 500 to 2000 μ g/mL. FIC index showed a synergistic effect of monolaurin with β ‐lactam antibiotics ranging from 0.0039 to 0.25 ( p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin’s capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC 50 values of 203.6 μ g/mL and 379.3 μ g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μ g/mL. Conclusion . Monolaurin had significant inhibitory effects on MRSA pre‐existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter‐associated infections.
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA.BackgroundMethicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA.The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene.MethodsThe agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene.Monolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL.ResultsMonolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL.Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.ConclusionMonolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. Methods. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC[sub.50]), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene. Results. Monolaurin exhibited MIC values ranging from 500 to 2000μ g/mL. FIC index showed a synergistic effect of monolaurin with β -lactam antibiotics ranging from 0.0039 to 0.25 (p<0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC[sub.50] values of 203.6μ g/mL and 379.3μ g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500μ g/mL. Conclusion. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.
Audience Academic
Author Mustafa, Ahmad
Osama El-Gendy, Ahmed
Abourehab, Mohammed A S
El-Beeh, Mohamed E
Ibrahem, Reham Ali
Azmy, Ahmed Farag
Abd El-Baky, Rehab Mahmoud
Hassan Abd El-Ghany, Shimaa Salah
Author_xml – sequence: 1
  givenname: Shimaa Salah
  orcidid: 0009-0007-3382-956X
  surname: Hassan Abd El-Ghany
  fullname: Hassan Abd El-Ghany, Shimaa Salah
  organization: Department of Microbiology and Immunology Faculty of Pharmacy Deraya University, Minia 11566, Egypt
– sequence: 2
  givenname: Ahmed Farag
  orcidid: 0000-0002-7347-9564
  surname: Azmy
  fullname: Azmy, Ahmed Farag
  organization: Department of Microbiology and Immunology Faculty of Pharmacy Beni-Suef University, Beni-Suef 62514, Egypt
– sequence: 3
  givenname: Ahmed
  orcidid: 0000-0002-0980-5185
  surname: Osama El-Gendy
  fullname: Osama El-Gendy, Ahmed
  organization: Department of Microbiology and Immunology Faculty of Pharmacy Beni-Suef University, Beni-Suef 62514, Egypt
– sequence: 4
  givenname: Rehab Mahmoud
  orcidid: 0000-0001-6094-5653
  surname: Abd El-Baky
  fullname: Abd El-Baky, Rehab Mahmoud
  organization: Department of Microbiology and Immunology Faculty of Pharmacy Minia University, Minia 61519, Egypt
– sequence: 5
  givenname: Ahmad
  orcidid: 0000-0001-7254-5665
  surname: Mustafa
  fullname: Mustafa, Ahmad
  organization: Faculty of Engineering October University for Modern Science and Arts (MSA), Giza, Egypt
– sequence: 6
  givenname: Mohammed A S
  surname: Abourehab
  fullname: Abourehab, Mohammed A S
  organization: Department of Pharmaceutics Faculty of Pharmacy Umm Al-Qura University, Makkah 21955, Saudi Arabia
– sequence: 7
  givenname: Mohamed E
  surname: El-Beeh
  fullname: El-Beeh, Mohamed E
  organization: Biology Department Al-Jumum University College Umm Al-Qura University, Makkah 21955, Saudi Arabia
– sequence: 8
  givenname: Reham Ali
  orcidid: 0000-0002-3249-4290
  surname: Ibrahem
  fullname: Ibrahem, Reham Ali
  organization: Department of Microbiology and Immunology Faculty of Pharmacy Minia University, Minia 61519, Egypt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39129910$$D View this record in MEDLINE/PubMed
BookMark eNptksuKFDEUhgsZcS66cy0BNy7smVwqVcmyGUZtmEHwgu7CqVx60lQlY5IS-gl8bdN226JIFiccvv9cOP95cxJisE3znOBLQji_opi2Vz0ngnXiUXNGOtEvJJHi5PgXX0-b85w3GHeCcvmkOWWSUCkJPmt-LEPxk9cpDh5GBMGgXWbw0flxQktd_Hdftig6dBdDHGFOPiBYgw-5oDtb7r324-jD4oPNPhcIBX0s8HC_HaOOWs8ZVYmtYZWruliDXIoT-hLn2moVnK0dYshPm8cOxmyfHeJF8_nNzafrd4vb929X18vbhWZ9XxbE9YYCde1AiOm46I3ujGGaMwOODD21zrV44MbVv3SOgmuht5RCr6EnhF00q31dE2GjHpKfIG1VBK9-JWJaK0jF69Gqoe0YdFZjEKbV3EBrOiYp5oMWVjtea73a13pI8dtsc1GTz9qOIwQb56wYrjSWTOCKvvwH3cQ5hbrpjiKMCynaP9Qaan8fXCwJ9K6oWgrc8jo_lZW6_A9Vn7H1kNUc9XL2b8HrvaBeOedk3XFvgtXOQ2rnIXXwUMVfHGadh8maI_zbNOwnAqrEqA
Cites_doi 10.1016/s0255-0857(21)02466-x
10.13005/ojc/340233
10.12669/pjms.38.8.6276
10.3389/fmicb.2018.02749
10.1038/sj.clpt.6100247
10.1111/j.1574-695x.2007.00357.x
10.5812/archcid.65744
10.1186/1756-0500-3-260
10.3390/pathogens2020288
10.1002/9781119246329.ch22
10.4103/jdmimsu.jdmimsu_156_21
10.1186/s12879-024-09261-9
10.1155/2013/378492
10.1186/1471-2105-7-85
10.1155/2019/8321834
10.1016/j.tim.2004.11.010
10.1007/s10096-017-3014-8
10.1007/s00203-017-1396-8
10.1002/cben.202100050
10.54393/pjhs.v3i04.139
10.1016/j.jhin.2012.07.010
10.2217/fmb.15.68
10.1111/j.1745-4530.2007.00178.x
10.1002/cmdc.202000677
10.1016/j.lwt.2020.109208
10.1208/s12249-014-0141-8
10.1186/1751-0147-54-69
10.3390/ijerph192114134
10.15376/biores.18.1.1554-1576
10.1128/JCM.00966-20
10.1371/journal.pone.0007499
10.1128/aac.00442-17
10.1371/journal.pone.0040350
10.1186/s40064-016-3182-5
10.1128/jcm.01864-19
10.1089/mdr.2018.0033
10.3390/diseases9040080
10.1089/mdr.2020.0001
10.1128/aac.47.4.1391-1394.2003
10.1038/nrmicro2415
10.3389/fmicb.2020.566325
10.1016/j.vetmic.2008.09.011
10.1186/s40360-017-0141-x
10.1038/s41522-022-00306-y
10.5144/0256-4947.2012.513
10.22207/jpam.17.1.44
10.1186/s12906-021-03293-3
10.1186/s13104-018-3820-9
10.1038/nrmicro.2016.94
10.3390/antibiotics9020059
10.1002/jobm.201700071
10.1111/j.1469-0691.2011.03570.x
10.1155/2016/5751785
10.1016/j.lwt.2016.03.045
10.1007/s13204-014-0301-x
10.3390/antibiotics11081083
10.1007/s43994-022-00018-1
10.1128/aac.02008-12
10.1385/1-59745-468-0:127
10.1038/nrd1008
ContentType Journal Article
Copyright Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al.
COPYRIGHT 2024 John Wiley & Sons, Inc.
Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
Copyright_xml – notice: Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al.
– notice: COPYRIGHT 2024 John Wiley & Sons, Inc.
– notice: Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0
DBID NPM
AAYXX
CITATION
3V.
7QL
7T7
7U9
7X7
7XB
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
CWDGH
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M7N
M7P
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOA
DOI 10.1155/2024/7518368
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Middle East & Africa Database
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Middle East & Africa Database
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
CrossRef
Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1687-9198
Editor Dilarri, Guilherme
Editor_xml – sequence: 1
  givenname: Guilherme
  surname: Dilarri
  fullname: Dilarri, Guilherme
– fullname: Guilherme Dilarri
ExternalDocumentID oai_doaj_org_article_b463a6ec0a8d4c5da4d639205bc8ecf5
A804511329
10_1155_2024_7518368
39129910
Genre Journal Article
GeographicLocations Egypt
GeographicLocations_xml – name: Egypt
GroupedDBID 188
24P
29J
2UF
2WC
3V.
4.4
53G
5GY
5VS
7X7
8FE
8FH
8FI
8FJ
8R4
8R5
AAFWJ
AAJEY
ABDBF
ABUWG
ACPRK
ADBBV
ADRAZ
AFKRA
AFPKN
AFRAH
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C1A
CCPQU
CEFSP
CNMHZ
CWDGH
DIK
E3Z
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IL9
IPNFZ
ITC
KQ8
LK8
M48
M7P
MM.
M~E
NPM
O5R
O5S
OK1
PGMZT
PIMPY
PQQKQ
PROAC
Q2X
RHU
RHX
RIG
RNS
RPM
TR2
TUS
UKHRP
UZ5
~8M
AAYXX
CITATION
7QL
7T7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c377t-1f7d2a2f4b11d6587dc6dd3c53daf1b72eff40b5dfb729ff2af4a7e22a7ca7113
IEDL.DBID M48
ISSN 1687-918X
IngestDate Tue Oct 22 15:15:01 EDT 2024
Sat Oct 26 04:26:33 EDT 2024
Thu Oct 10 22:19:46 EDT 2024
Wed Oct 16 18:02:07 EDT 2024
Tue Oct 15 04:49:24 EDT 2024
Thu Aug 22 14:18:08 EDT 2024
Sat Nov 02 12:16:13 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c377t-1f7d2a2f4b11d6587dc6dd3c53daf1b72eff40b5dfb729ff2af4a7e22a7ca7113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3249-4290
0000-0001-7254-5665
0000-0002-7347-9564
0000-0001-6094-5653
0000-0002-0980-5185
0009-0007-3382-956X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2024/7518368
PMID 39129910
PQID 3091358984
PQPubID 237261
ParticipantIDs doaj_primary_oai_doaj_org_article_b463a6ec0a8d4c5da4d639205bc8ecf5
proquest_miscellaneous_3092009380
proquest_journals_3091358984
gale_infotracmisc_A804511329
gale_infotracacademiconefile_A804511329
crossref_primary_10_1155_2024_7518368
pubmed_primary_39129910
PublicationCentury 2000
PublicationDate 2024-00-00
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024-00-00
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: New York
PublicationTitle International journal of microbiology
PublicationTitleAlternate Int J Microbiol
PublicationYear 2024
Publisher John Wiley & Sons, Inc
Hindawi Limited
Publisher_xml – name: John Wiley & Sons, Inc
– name: Hindawi Limited
References e_1_2_13_24_2
e_1_2_13_26_2
e_1_2_13_45_2
e_1_2_13_20_2
e_1_2_13_43_2
e_1_2_13_22_2
e_1_2_13_64_2
e_1_2_13_8_2
e_1_2_13_62_2
e_1_2_13_6_2
e_1_2_13_60_2
Krislee A. (e_1_2_13_47_2) 2019
e_1_2_13_17_2
e_1_2_13_38_2
Jafari-Sales A. (e_1_2_13_41_2) 2018; 1
e_1_2_13_13_2
e_1_2_13_34_2
e_1_2_13_15_2
e_1_2_13_36_2
e_1_2_13_57_2
Tajik H. (e_1_2_13_50_2) 2014; 1
e_1_2_13_30_2
e_1_2_13_55_2
e_1_2_13_11_2
e_1_2_13_32_2
e_1_2_13_51_2
Wang H. (e_1_2_13_53_2) 2020; 124
Mochtar C. F. (e_1_2_13_59_2) 2021; 13
e_1_2_13_4_2
e_1_2_13_2_2
e_1_2_13_27_2
e_1_2_13_29_2
e_1_2_13_23_2
e_1_2_13_48_2
e_1_2_13_25_2
e_1_2_13_46_2
e_1_2_13_44_2
e_1_2_13_65_2
e_1_2_13_21_2
e_1_2_13_42_2
e_1_2_13_63_2
e_1_2_13_61_2
e_1_2_13_7_2
e_1_2_13_40_2
e_1_2_13_5_2
e_1_2_13_9_2
Mader R. (e_1_2_13_31_2) 2021; 26
e_1_2_13_16_2
e_1_2_13_39_2
e_1_2_13_18_2
e_1_2_13_12_2
e_1_2_13_37_2
e_1_2_13_56_2
e_1_2_13_54_2
e_1_2_13_10_2
e_1_2_13_33_2
e_1_2_13_52_2
Schlievert P. M. (e_1_2_13_58_2) 2012; 7
Mishra R. (e_1_2_13_35_2) 2020; 11
Khan A. A. (e_1_2_13_14_2) 2017
e_1_2_13_3_2
e_1_2_13_1_2
e_1_2_13_28_2
e_1_2_13_49_2
Albano M. (e_1_2_13_19_2) 2020; 59
References_xml – start-page: 1
  volume-title: BMC Proceedings
  year: 2019
  ident: e_1_2_13_47_2
  contributor:
    fullname: Krislee A.
– ident: e_1_2_13_22_2
  doi: 10.1016/s0255-0857(21)02466-x
– ident: e_1_2_13_48_2
  doi: 10.13005/ojc/340233
– ident: e_1_2_13_56_2
  doi: 10.12669/pjms.38.8.6276
– ident: e_1_2_13_23_2
  doi: 10.3389/fmicb.2018.02749
– ident: e_1_2_13_6_2
  doi: 10.1038/sj.clpt.6100247
– ident: e_1_2_13_3_2
  doi: 10.1111/j.1574-695x.2007.00357.x
– ident: e_1_2_13_1_2
  doi: 10.5812/archcid.65744
– ident: e_1_2_13_63_2
  doi: 10.1186/1756-0500-3-260
– ident: e_1_2_13_32_2
  doi: 10.3390/pathogens2020288
– start-page: 439
  volume-title: Biofilms in Plant and Soil Health
  year: 2017
  ident: e_1_2_13_14_2
  doi: 10.1002/9781119246329.ch22
  contributor:
    fullname: Khan A. A.
– ident: e_1_2_13_42_2
  doi: 10.4103/jdmimsu.jdmimsu_156_21
– ident: e_1_2_13_52_2
  doi: 10.1186/s12879-024-09261-9
– ident: e_1_2_13_64_2
  doi: 10.1155/2013/378492
– ident: e_1_2_13_29_2
  doi: 10.1186/1471-2105-7-85
– ident: e_1_2_13_38_2
  doi: 10.1155/2019/8321834
– ident: e_1_2_13_11_2
  doi: 10.1016/j.tim.2004.11.010
– ident: e_1_2_13_43_2
  doi: 10.1007/s10096-017-3014-8
– volume: 1
  start-page: 108
  year: 2014
  ident: e_1_2_13_50_2
  article-title: Effect of monolaurin alone and in combination with EDTA on viability of Escherichia coli and Staphylococcus aureus in culture media and iranian white cheese
  publication-title: Journal of Food Quality and Hazards Control
  contributor:
    fullname: Tajik H.
– ident: e_1_2_13_27_2
  doi: 10.1007/s00203-017-1396-8
– ident: e_1_2_13_65_2
  doi: 10.1002/cben.202100050
– ident: e_1_2_13_36_2
  doi: 10.54393/pjhs.v3i04.139
– ident: e_1_2_13_62_2
  doi: 10.1016/j.jhin.2012.07.010
– ident: e_1_2_13_51_2
  doi: 10.2217/fmb.15.68
– ident: e_1_2_13_18_2
  doi: 10.1111/j.1745-4530.2007.00178.x
– ident: e_1_2_13_30_2
  doi: 10.1002/cmdc.202000677
– volume: 124
  year: 2020
  ident: e_1_2_13_53_2
  article-title: Antibacterial effects of Lactobacillus acidophilus surface-layer protein in combination with nisin against Staphylococcus aureus
  publication-title: LWT
  doi: 10.1016/j.lwt.2020.109208
  contributor:
    fullname: Wang H.
– ident: e_1_2_13_26_2
  doi: 10.1208/s12249-014-0141-8
– ident: e_1_2_13_28_2
  doi: 10.1186/1751-0147-54-69
– volume: 26
  year: 2021
  ident: e_1_2_13_31_2
  article-title: EU-JAMRAI building the European antimicrobial resistance surveillance network in veterinary medicine (EARS-Vet)
  publication-title: Euro Surveillance
  contributor:
    fullname: Mader R.
– ident: e_1_2_13_37_2
  doi: 10.3390/ijerph192114134
– ident: e_1_2_13_13_2
  doi: 10.15376/biores.18.1.1554-1576
– volume: 59
  year: 2020
  ident: e_1_2_13_19_2
  article-title: Comparison of agar dilution to broth microdilution for testing in vitro activity of cefiderocol against gram-negative bacilli
  publication-title: Journal of Clinical Microbiology
  doi: 10.1128/JCM.00966-20
  contributor:
    fullname: Albano M.
– ident: e_1_2_13_15_2
  doi: 10.1371/journal.pone.0007499
– ident: e_1_2_13_61_2
  doi: 10.1128/aac.00442-17
– volume: 7
  year: 2012
  ident: e_1_2_13_58_2
  article-title: Glycerol monolaurate antibacterial activity in broth and biofilm cultures
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0040350
  contributor:
    fullname: Schlievert P. M.
– ident: e_1_2_13_60_2
  doi: 10.1186/s40064-016-3182-5
– ident: e_1_2_13_16_2
  doi: 10.1128/jcm.01864-19
– ident: e_1_2_13_2_2
  doi: 10.1089/mdr.2018.0033
– volume: 1
  start-page: 71
  year: 2018
  ident: e_1_2_13_41_2
  article-title: Study of antibiotic resistance pattern in methicillin-resistant Staphylococcus aureus isolated from clinical samples of hospitals in Tabriz–Iran
  publication-title: International Journal of Biomedicine and Public Health
  contributor:
    fullname: Jafari-Sales A.
– ident: e_1_2_13_57_2
  doi: 10.3390/diseases9040080
– ident: e_1_2_13_55_2
  doi: 10.1089/mdr.2020.0001
– ident: e_1_2_13_25_2
  doi: 10.1128/aac.47.4.1391-1394.2003
– ident: e_1_2_13_10_2
  doi: 10.1038/nrmicro2415
– volume: 11
  year: 2020
  ident: e_1_2_13_35_2
  article-title: Natural anti-biofilm agents: strategies to control biofilm-forming pathogens
  publication-title: Frontiers in Microbiology
  doi: 10.3389/fmicb.2020.566325
  contributor:
    fullname: Mishra R.
– ident: e_1_2_13_4_2
  doi: 10.1016/j.vetmic.2008.09.011
– ident: e_1_2_13_44_2
  doi: 10.1186/s40360-017-0141-x
– ident: e_1_2_13_8_2
  doi: 10.1038/s41522-022-00306-y
– ident: e_1_2_13_39_2
  doi: 10.5144/0256-4947.2012.513
– ident: e_1_2_13_40_2
  doi: 10.22207/jpam.17.1.44
– ident: e_1_2_13_24_2
  doi: 10.1186/s12906-021-03293-3
– ident: e_1_2_13_21_2
  doi: 10.1186/s13104-018-3820-9
– ident: e_1_2_13_9_2
  doi: 10.1038/nrmicro.2016.94
– ident: e_1_2_13_7_2
  doi: 10.3390/antibiotics9020059
– ident: e_1_2_13_33_2
  doi: 10.1002/jobm.201700071
– volume: 13
  year: 2021
  ident: e_1_2_13_59_2
  article-title: Inhibitory and eradication activities of 1-monolaurin as anti-biofilm on monospecies and polymicrobial of Staphylococcus epidermidis and Candida tropicalis
  publication-title: International Journal of Pharmaceutical Research
  contributor:
    fullname: Mochtar C. F.
– ident: e_1_2_13_17_2
  doi: 10.1111/j.1469-0691.2011.03570.x
– ident: e_1_2_13_12_2
  doi: 10.1155/2016/5751785
– ident: e_1_2_13_49_2
  doi: 10.1016/j.lwt.2016.03.045
– ident: e_1_2_13_46_2
  doi: 10.1007/s13204-014-0301-x
– ident: e_1_2_13_20_2
  doi: 10.3390/antibiotics11081083
– ident: e_1_2_13_45_2
  doi: 10.1007/s43994-022-00018-1
– ident: e_1_2_13_34_2
  doi: 10.1128/aac.02008-12
– ident: e_1_2_13_5_2
  doi: 10.1385/1-59745-468-0:127
– ident: e_1_2_13_54_2
  doi: 10.1038/nrd1008
SSID ssj0068259
Score 2.3429015
Snippet Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study...
Background . Methicillin‐resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life‐threatening infections, showing resistance...
Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to...
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various...
SourceID doaj
proquest
gale
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 7518368
SubjectTerms Amides
Antibiotics
Antimicrobial agents
Bacteria
Biofilms
Catheters
Cell culture
Dilution
Drug resistance
Drug resistance in microorganisms
Electron microscopy
Gene expression
Glycerol
Gram-positive bacteria
Health aspects
Imipenem
Impact resistance
Infection
Medical instruments
Methicillin
Microorganisms
Polymerase chain reaction
Reverse transcription
Scanning electron microscopy
Staphylococcus aureus
Staphylococcus aureus infections
Staphylococcus infections
Synergistic effect
Tetracycline
Tetracyclines
Tissue culture
Wound infection
β-Lactam antibiotics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBglwJxClqEtuxc1yqVm2lckBU9Gb5NWgP9Vbd7IFfwN9mJs6uWjhw4ZQocRTbM-P5xpl8w9gH2cZkMNypJXrPWuJqULuUfK099Kk3RP9C-x0XX_rTS3l-pa7ulPqinLBCD1wm7tDLXrg-hcaZKIOKTkZ0ql2jfDApQGEvbYZtMFXW4B7jnmGb5q4URfjykD4wCKJUveOAJp7-v1fjPzDm5GtOnrDHM0jki9K5p-xBys_Yw1I28udz9muRx-X1cqJQwmYuR05X_JLKb1_zRSgVIfgKOJosxq60o87dD7dELMgvEqW40zZLrr-mNeHHPHIEnTjh6NlWIWzWHB9JeDhDzUQwGjn9hcK_Uwkmfjanb-X1C3Z5cvzt6LSeCyrUQWg91i3o2LkOpG_biNBDx9DHKIIS0UHrdZcAZONVBDwfADoH0unUdU4Hp9tWvGR7eZXTa8ZRlgLf5jVAkk7CAFG4AMEbqnc1yIp93M6yvSm8GXaKN5SyJA07S6Nin0kEuzbEdj1dQB2wsw7Yf-lAxT6RAC3Z5Hjrgpt_LcCuEruVXRhi0cG4e6jY_r2WaEvh_u2tCtjZltdWEHWqMoPBQR3sbtOTlJ-W02oztaHPTMI0FXtVVGc3JDEgpkJU9uZ_DPUte0TTVzaB9tneeLtJ7xAWjf79ZAG_AeKUDsM
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICOBOEVdx3bsnNCCqFqkckBU7M3ys9pDnbLJHvgF_G1mEu9CQeKUKHaeM2N_M558Q8hrwULU4O7UAmbPWsBoUNsYXa1camOrkf4F4x1nn9uTc_FpJVcl4DaUtMrdmDgN1KH3GCM_4khgKXWnxbur7zVWjcLV1VJC4ya5xRpQXtBntdo7XC14Pwh_WQuG1DG92iW-S4k-vzjCJQeOJKt_TEkTc_-_4_NfqHOafY7vkbsFNtLlLOf75EbMD8jtuZDkj4fk5zKP68v1RKoE3WwOFI-4NRbkvqRLP9eIoH2iYMTgzWKMndoLuwZ0SM8iJr1j4CXXX-KAiDKPFGAoiADmut777UDhlAibU9BVgKeB4n8p9BsWZaKnJaErD4_I-fHHrx9O6lJiofZcqbFmSYXGNkk4xgKAERV8GwL3kgebmFNNTEksnAwJ9ruUGpuEVbFprPJWMcYfk4Pc5_iUUJAuh7s5lVIUVqQuBW598k5jBaxOVOTN7iubq5lJw0weiJQGpWGKNCryHkWw74P819OBfnNhijkZJ1pu2-gXVgfhZbAiANRqFtJ5HX2SFXmLAjRopePGelt-NoBHRb4rs9TIqwOeeFeRw2s9wbr89eadCphi3YP5rYsVebVvxjMxYy3Hfjv1wYUnrhcVeTKrzv6VeAcoC3Das_9f_Dm5gx9mDvgckoNxs40vAAKN7uWk578AzrgHJg
  priority: 102
  providerName: ProQuest
Title Antimicrobial and Antibiofilm Activity of Monolaurin against Methicillin-Resistant Staphylococcus aureus Isolated from Wound Infections
URI https://www.ncbi.nlm.nih.gov/pubmed/39129910
https://www.proquest.com/docview/3091358984
https://www.proquest.com/docview/3092009380
https://doaj.org/article/b463a6ec0a8d4c5da4d639205bc8ecf5
Volume 2024
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELb2ISQuiPcWlspIIE6BOrZj54BQF-3SRdoVqqjILfJzVYlNoE0l9hfwt5nJo1IXDlySKLHV2jMTfzOefEPIK8F80ODuJAJWz0TA2yAxIdhE2ZiFTCP9C8Y7Li6z2UJ8LmSxR4Zqo_0Erv_p2mE9qcXq-9tfP28-gMG_bw1eSvTfxTvcPuCZ3ieHKVJyYRKf2O4nZOAHIRBmGZhUznQxpMDf6r2zOLUc_n-_qW_hz3YdOrtP7vUAkk47iT8ge6F6SO50JSVvHpHf06pZXi9beiVoZipP8Y5dYmnuazp1XbUIWkcK5gyDx2g7NVdmCTiRXgRMf8cQTJXMwxqxZdVQAKQgDFj1auc2awpdApzOQWsBqHqKX6jQb1ieiZ73qV3V-jFZnJ1-_ThL-mILieNKNQmLyqcmjcIy5gGWKO8y77mT3JvIrEpDjGJipY9wnceYmiiMCmlqlDOKMf6EHFR1FY4IBTlz-DWrYgzCiJhHz42LzmqshZWLEXk9zHL5o-PUKFtfRMoSpVH20hiRExTBtg0yYbc36tVV2RtWaUXGTRbcxGgvnPRGeABd6URap4OLckTeoABL1KBmZZzpPzuAv4rMV-VUI8MO-OT5iBzvtAQ7c7uPBxUoBzUtOdKqSp1rGNTL7WPsiblrVag3bRvcguJ6MiJPO9XZDonngLcAsT37j97PyV2cnS7-c0wOmtUmvABE1Ngx2VeFGpPDk9PLL_NxG1eA46eCjVszgON8VvwB3-gQYw
link.rule.ids 315,783,787,866,867,2109,4033,12070,21402,24332,27937,27938,27939,31733,31734,33758,33759,43324,43819,74081,74638
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEF8SwpBYwE4hR1E9uxc0ILotqFbg-oFXuz_Kz20KRssgd-Qf82M4l3oSBxShQ7z5mxvxlPviHkLS98UODu5Bxmz5zDaJCbEGwubaxCpZD-BeMdi9Nqds6_LMUyBdy6lFa5HROHgdq3DmPkRwwJLIWqFf9w9SPHqlG4uppKaNwmd5CHC7nz5XLncFXg_SD8LSowpLpQy23iuxDo8_MjXHJgSLL6x5Q0MPf_Oz7_hTqH2ef4IXmQYCOdjnJ-RG6F5jG5OxaS_PmEXE-bfnW5GkiVoJtpPMUjdoUFuS_p1I01ImgbKRgxeLMYY6fmwqwAHdJFwKR3DLw0-bfQIaJsegowFEQAc13r3KajcEqAzRx0FeCpp_hfCv2ORZnoPCV0Nd1Tcn78-ezTLE8lFnLHpOzzIkpfmjJyWxQewIj0rvKeOcG8iYWVZYiRT6zwEfbrGEsTuZGhLI10RhYFe0b2mrYJzwkF6TK4m5UxBm54rKNnxkVnFVbAqnlG3m2_sr4amTT04IEIoVEaOkkjIx9RBLs-yH89HGjXFzqZk7a8YqYKbmKU5054wz1ArXIirFPBRZGR9yhAjVbar40z6WcDeFTku9JThbw64InXGTm80ROsy91s3qqATtbd6d-6mJE3u2Y8EzPWmtBuhj648MTUJCP7o-rsXonVgLIApx38_-Kvyb3Z2eJEn8xPv74g9_EjjcGfQ7LXrzfhJcCh3r4adP4XWKMKFg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYgL4rlkWcBIIE5Rm9iOnRMqj2oL7AohVvRm-bnqYZPdJj3wC_jbzCRuYUHi1Cp2mjQz4_lmPPmGkJe88EFBuJNz8J45h9UgNyHYXNpYhUoh_QvmO45PqqNT_nEplqn-qUtllds1cViofeswRz5hSGApVK34JKayiC_v528uLnPsIIU7ramdxnVyQ3JwdKDbcrkLviqIhBAKFxUYVV2o5bYIXgiM__kEtx8YEq7-4Z4GFv9_1-q_EOjgieZ3yZ0EIelslPk9ci0098nNsankjwfk56zpV-ergWAJppnGUzxiV9ic-5zO3NgvgraRgkFDZIv5dmrOzAqQIj0OWACPSZgm_xo6RJdNTwGSgjjA77XObToKpwT4WIDeAlT1FN9Rod-xQRNdpOKupntITucfvr07ylO7hdwxKfu8iNKXpozcFoUHYCK9q7xnTjBvYmFlGWLkUyt8hO91jKWJ3MhQlkY6I4uCPSJ7TduEx4SCpBlczcoYAzc81tEz46KzCrth1Twjr7ZPWV-MrBp6iEaE0CgNnaSRkbcogt0c5MIeDrTrM51MS1teMVMFNzXKcye84R5gVzkV1qngosjIaxSgRovt18aZ9OIB3CpyX-mZQo4diMrrjBxemQmW5q4Ob1VAJ0vv9G-9zMiL3TCeidVrTWg3wxzchGJqmpH9UXV2f4nVgLgAsx38_8efk1ug7vrz4uTTE3Ibn9GYBzoke_16E54CMurts0HlfwG-4g5L
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+and+Antibiofilm+Activity+of+Monolaurin+against+Methicillin-Resistant+Staphylococcus+aureus+Isolated+from+Wound+Infections&rft.jtitle=International+journal+of+microbiology&rft.au=Hassan+Abd+El-Ghany%2C+Shimaa+Salah&rft.au=Azmy%2C+Ahmed+Farag&rft.au=Osama+El-Gendy%2C+Ahmed&rft.au=Abd+El-Baky%2C+Rehab+Mahmoud&rft.date=2024&rft.issn=1687-918X&rft.volume=2024&rft.spage=7518368&rft_id=info:doi/10.1155%2F2024%2F7518368&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-918X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-918X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-918X&client=summon